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The C57BLKS/J (BKS) inbred mouse strain is a widely used animal model of type 2 diabetes. In the presence of the diabetes (db) mutation,
obese BKS-db mice develop severe diabetes. Genetic studies of diabetes-susceptibility in this strain are facilitated by the fact that BKS is a genetic
composite between the diabetes-resistant C57BL/6J (B6) and susceptible DBA/2J (DBA) strains. On this basis, it has been hypothesized that
diabetes-susceptibility in BKS is conferred by DBA-derived alleles. However, recent studies revealed non-B6/non-DBA genetic material in BKS.
To identify the origin of this genetic component, we generated a genomic map of BKS using 537 microsatellite markers. Our results demonstrate
that, in addition to B6 and DBA, BKS contains alleles from at least three other strains, including 129, C57BL/10 and an unidentified mouse strain.
We also analyzed two congenic strains, B6-db and BKS-db, which are widely used for the genetic mapping of diabetes-susceptibility loci. We
identified several donor-derived genomic regions introduced during the generation of these congenic strains. In summary, our study reveals novel
aspects of the genetic fine-structure of BKS and related strains and facilitates the identification of diabetes-susceptibility loci in this mouse model.
© 2006 Elsevier B.V. All rights reserved.Keywords: Type 2 diabetes mellitus; Animal model; C57BLKS mouse strain; Leptin receptor mutation; Microsatellite marker1. Introduction
Obesity is recognized as a major risk factor for the
development of type 2 diabetes. However, only a subset of
obese individuals is diabetic, whereas the rest remain disease
free [1]. Despite the biomedical importance of these diseases,
the factors determining diabetes-susceptibility in obese indivi-
duals are still unknown.
As inbred strains of mice show markedly different suscept-
ibilities to obesity-induced diabetes, the mouse is an excellent
model organism for genetic studies of this disease [2]. One of the
best-characterized models involves the C57BL/6J (B6) andAbbreviations: B6, C57BL/6J; B10, C57BL/10J; BKS, C57BLKS/J; Chr
chromosome; db, diabetes mutation; QTL, quantitative trait locus; SNP, single
nucleotide polymorphism
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doi:10.1016/j.bbadis.2006.01.002,C57BLKS/J (BKS) strains with the homozygous diabetes (db)
mutation, a genetic defect in the leptin receptor gene [3]. Obese
B6-Leprdb/Leprdb (B6-db) mice exhibit well-compensated
diabetes characterized by mildly elevated glucose levels,
hyperinsulinemia, and pancreatic islet hypertrophy. In contrast,
similarly obese BKS-Leprdb/Leprdb (BKS-db) mice develop
severe diabetes associated with dramatically reduced insulin
levels and islet atrophy. The two mouse strains display similar
phenotypic differences in the presence of the obese (ob)
mutation, a genetic defect of the leptin gene [4]. These
observations indicate the presence of different genetic modifiers
of diabetes in B6 and BKSmice. Early genetic studies suggested
that diabetes-susceptibility in these strains is under multigenic
control [5], andmore recently, suggestive loci for plasma glucose
were detected [6]. However, the genes underlying diabetes-
susceptibility in this mouse model remain to be identified.
The BKS strain is the result of an inadvertent genetic
contamination. In 1947, a wildfire destroyed the mouse colonies
of The Jackson Laboratory and, in order to re-establish the B6
colony, a breeding pair was obtained from the Sloan-Kettering
Institute in 1948. However, characterization of the re-derived
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genetically distinct from B6, and was named C57BLKS
(BKS). Subsequent systematic genetic analysis of the BKS
strain revealed that it was the result of a genetic contamination
of the B6 strain with DBA/2J (DBA) [7]. A recent analysis of
the BKS genome using SNP markers demonstrated that 71% of
the BKS genome is derived from B6 and 29% is from the DBA
strain [8].
Similarly to BKS-db mice, DBA-db mice are also suscep-
tible to diabetes indicating that, in contrast to B6, the DBA
strain background is diabetogenic [9]. On this basis, it has been
widely assumed that the DBA-derived genetic component of
BKS is responsible for diabetes-susceptibility in this strain.
However, recent studies suggest that, in addition to B6- and
DBA-derived DNA, BKS may carry additional genetic material
[8]. Using high-resolution SNP mapping, we demonstrated that
as much as 9% of the BKS genome originates from a non-B6/
non-DBA donor [10]. A comparison of non-B6/non-DBA SNPs
in BKS to a panel of inbred strains failed to identify the strain of
origin, partly due to the bi-allelic nature and low information
content of SNP markers. Thus, the source of non-B6/non-DBA
genetic material in BKS remains to be determined. In the
present study, we provide a high-resolution microsatellite map
of the BKS genome, which allowed us to identify the location
and strain origin of the non-B6/non-DBA genetic component.
Genetic mapping of diabetes-susceptibility loci in the BKS
strain requires a cross between B6 and BKS mice segregating
the db mutation. Two congenic strains with the db mutation are
currently available for such crosses, B6-db and BKS-db. We
assessed the genetic purity of these congenics by high-
resolution microsatellite marker analysis. Our results indicate
the presence of several donor-derived contaminating chromo-Table 1
Marker distribution along the chromosomes
Chr Chromosome length (Mbp) Number of markers Minimal
1 200 36 (29) 0.596 (0.5
2 181 37 (24) 0.004 (0.0
3 160 29 (17) 0.025 (0.0
4 153 38 (24) 0.205 (0.4
5 150 35 (23) 0.053 (0.0
6 150 20 (13) 1.356 (1.7
7 140 31 (24) 0.030 (0.1
8 130 29 (17) 0.100 (1.4
9 130 28 (16) 0.715 (0.7
10 130 24 (13) 0.131 (0.3
11 120 46 (41) 0.035 (0.0
12 110 22 (15) 0.288 (0.2
13 120 21 (17) 0.117 (0.1
14 120 23 (16) 0.247 (0.7
15 100 26 (15) 0.005 (0.1
16 99 17 (12) 0.733 (1.8
17 94 21 (15) 0.399 (0.7
18 91 19 (9) 0.688 (2.9
19 61 20 (17) 0.267 (0.2
X 160 15 (12) 0.985 (1.0
Total 2599 537 (369)
Average 0.349 (0.6
a Distances refer to a composite map including data from Naggert et al. and Slings
only.somal regions in these congenic strains, which has implications
for genetic mapping studies of diabetes-susceptibility in this
mouse model.
2. Materials and methods
2.1. Mouse strains
DNA samples from C57BL/6J (stock #664), DBA/2J (671), C57BLKS/J
(662), B6.Cg-Leprdb/Leprdb (697), BKS.Cg-Leprdb/Leprdb (642), C57BL/10J
(665) and 129S1/SvImJ (2448) were obtained from the Mouse DNA Resource at
The Jackson Laboratory.
2.2. Genotyping
Fluorophore-labeled primers for microsatellite amplification were obtained
from Research Genetics-Invitrogen (Carlsbad, CA). PCRs were performed in
96-well format using 25 ng genomic DNA template and recombinant Taq
DNA polymerase (Invitrogen) in 6 μl reaction volumes. A touch-down
protocol consisting of 95 °C/5 min initial denaturation, 16 cycles of 95 °C/45
s, 58–50 °C (decreased by 0.5 °C/cycle increments)/30 s, and 72 °C/45 s,
followed by a final 72 °C/6 min extension step. After PCR, 1 μl aliquots
were diluted 10-fold with water and 2 μl of the diluted samples were mixed
with 10 μl of HiDi formamide containing GeneScan 500 LIZ size standard in
a 96-well optical plate (Applied Biosystems, Foster City, CA). Samples were
denatured at 95 °C/5 min, cooled on ice, briefly spun and kept frozen until
electrophoresis. PCR products were run on an ABI 3700 capillary sequencer
at the UCLA Genotyping Core Facility. Data analysis was performed using
the Genotyper 3.7 software (Applied Biosystems).
3. Results
3.1. High-resolution microsatellite map of the BKS genome
For initial genotyping of the BKS strain, we used a panel of
348 microsatellite markers polymorphic between B6 and DBAdistancea (Mbp) Maximal distancea (Mbp) Average distancea (Mbp)
95) 16.97 (16.97) 6.667 (8.356)
57) 18.92 (21.12) 5.485 (7.542)
25) 17.90 (30.38) 5.926 (8.889)
97) 18.62 (18.62) 4.500 (6.652)
53) 17.12 (23.02) 4.839 (7.895)
91) 16.37 (40.25) 8.333 (12.50)
30) 13.07 (18.66) 4.667 (5.833)
84) 16.04 (27.73) 4.815 (8.125)
15) 23.01 (23.10) 5.535 (8.667)
82) 37.83 (58.93) 5.417 (10.00)
35) 12.80 (16.09) 2.609 (5.000)
88) 16.89 (18.05) 6.471 (8.462)
17) 19.86 (23.75) 5.714 (8.000)
23) 16.27 (19.34) 5.273 (7.500)
22) 20.73 (20.73) 4.000 (6.933)
42) 19.46 (26.03) 4.700 (8.250)
66) 15.23 (19.46) 6.300 (5.875)
42) 21.43 (21.43) 4.789 (10.11)
67) 15.93 (15.93) 3.813 (4.067)
63) 35.30 (35.30) 11.43 (13.33)
95) 19.49 (24.75) 5.564 (8.100)
by et al. Numbers in parentheses were calculated based on data from this study
442 H.Z. Mao et al. / Biochimica et Biophysica Acta 1762 (2006) 440–446[11]. Subsequently, 21 additional markers were typed in regions
of interest, as discussed below. The chromosomal distribution
and inter-marker distances are shown in Table 1. The allele
distribution of the randomly distributed initial marker setFig. 1. Composite microsatellite map of the BKS genome. Black boxes represent D
where markers exhibit non-B6/non-DBA alleles. The symbols for the Mit microsate
10 Mbp.indicates that 71% of the BKS genome is derived from B6, 25%
from DBA and 4% of markers exhibit alleles different from
both, in agreement with recent estimates based on SNP
genotyping [8,10].BA-derived chromosomal regions and empty boxes indicate genomic intervals
llite markers have been abbreviated. Tick marks on chromosomes are spaced at
Table 2
Location of non-B6/non-DBA markers in BKS
Chr Marker Position
(Mbp)
Allelea Probability
of de novo
mutations
in cluster
(%)b
Chr region detected
in SNP studies
Petkov
et al. [8]
Davis
et al. [10]
1 D1Mit122 40.8 other no yes
3 D3Mit17 c 144.2 7.8 no yes
D3Mit84 144.3 129
4 D4Mit246 97.0 129 4.7×10−2 yes yes
D4Mit155 100.9 129
D4Mit308 122.5 129
D4Mit16 126.5 129
D4Mit13 141.0 B10 no no
5 D5Mit431 117.3 other 7.8 no yes
D5Mit367 117.3 other
7 D7Mit253 102.9 other 7.8 no no
D7Mit238 106.4 129
8 D8Mit177 (31.7 cM) d B10
9 D9Mit126 23.1 other 7.8 yes yes
D9Mit64 28.5 other
D9Mit259 70.1 other 0.61 no yes
D9Mit156 75.0 other
D9Mit305 75.7 other
10 D10Mit2 21.3 other no no
D10Mit15 66.8 B10 no no
11 D11Mit71 e 6.8 B10 no yes
D11Mit130 44.5 other no no
D11Mit139e 48.8 B10 2.9×10−4 no yes
D11Mit153e 49.5 B10
D11Mit24 53.1 B10
D11Mit111e 53.3 B10
D11Mit241 54.2 B10
D11Mit272 55.5 B10
D11Mit118e 80.2 yes yes
13 D13Mit139 50.8 129 no no
D13Mit146 96.8 129 no no
D13Mit77 113.9 other no yes
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BKS genome, we combined our data set (369 markers) with
those generated previously by Naggert et al. (161 markers) [7]
and Slingsby et al. (19 markers) [12], as shown in Fig. 1. As a
result of significantly increased marker density, the new map
defines the boundaries of genomic segments at considerably
higher precision than the previous microsatellite map [7]. The
locations of DBA-derived regions obtained in our study are
generally in good agreement with those in SNP-based maps
[8,10]. However, some of the DBA-derived segments reported
here were undetected by the SNP studies (e.g., those on
proximal Chr 2 and distal Chr 13), probably due to the limited
degree of polymorphism of SNPs compared to microsatellite
markers.
3.2. The origin of non-B6/non-DBA regions in BKS
Although several previous studies recognized the presence of
non-B6/non-DBA alleles in the BKS genome, the origin of
these alleles is currently unclear. Naggert et al. hypothesized
that non-B6/non-DBA alleles represent mutations, which
accumulated since the origin of the BKS strain [7]. In contrast,
results by Slingsby et al. indicate that some of these alleles
cluster in the genome and may be of C57BL/10 (B10) origin
[12]. In a recent large-scale SNP genotyping study, the non-B6/
non-DBA SNP pattern in BKS best matched that of BTBR T+tf/
J (BTBR) among 102 strains tested [8].
As the BTBR strain was established several years after the
genetic contamination of B6 resulting in BKS [13], BTBR itself
cannot be the contaminating strain. However, BTBR is
genetically closely related to the 129 strain [13], which was
derived in the late 1920s, many years before BKS originated
[14]. To test the hypothesis that BKS contains genetic
contribution from 129, we compared microsatellite allele sizes
between the BKS and the 129S1/SvImJ (129) strains. Since
previous work indicated the presence of B10 alleles in BKS
[12], we also included the B10 strain in our analysis. We
genotyped 15 microsatellite markers exhibiting non-B6/non-
DBA alleles in our original screen of the BKS genome and
subsequently tested additional markers in the vicinity of the 15
core markers.
As listed in Table 2, a total of 42 markers showed non-B6/
non-DBA alleles. The majority (69%) of these markers occur in
chromosomal regions recognized as non-B6/non-DBA-derived
in previous SNP studies [8, 10]. This observation indicates thatNotes to Table 2:
Markers representing contiguous chromosomal segments are grouped together.
a Abbreviations: 129S1/SvImJ, 129; C57BL/10, B10; other, different from
B6, DBA, 129 and B10.
b Probability of de novo-mutated microsatellites occurring in cluster
calculated as 0.078n-1x100%, where 0.078 is the frequency of non-B6/non-
DBA alleles (42 out of 537) and ‘n' is the number of markers in the cluster.
c Different from B6 and DBA according to Naggert et al. (1995); not
analyzed in this study.
d As physical position for this marker is not available in UniSTS, genetic
location is provided.
e Data from Slingsby et al. (1995); not analyzed in this study.these alleles are not the result of de novo mutations accumulated
since the separation of the BKS strain, but they are derived from
a strain(s) other than B6 and DBA. Frequent clustering of non-
B6/non-DBA alleles (e.g., Chr 4, 9 and 11) also indicates that15 D15Mit134 83.4 other 0.61 no yes
D15Mit33 84.1 129
D15Mit37 87.0 129
D15Mit243 93.4 other 7.8 yes yes
D15Mit76 95.4 other
17 D17Mit221 88.7 B10 no no
18 D18Mit110 12.1 other 7.8 no no
D18Mit20 15.1 other
19 D19Mit42 9.2 other no no
X DXMit211 80.7 other no no
Table 3
Donor-derived alleles in the BKS-db and B6-db congenic strains
Strain Chr Marker Position
(Mbp)
Allele in
congenics a
Allele in
background
strain
BKS-db 1 D1Mit122 40.8 DBA other
5 D5Mit431 117.3 other other b
17 D17Mit52 41.7 DBA B6
19 D19Mit68 3.4 other B6
D19Mit42 9.2 B6 other
D19Mit40 24.6 other DBA
B6-db 4 D4Mit31 105.5 DBA B6
D4Mit308 122.5 het c B6
D4Mit249 124.1 het d B6
5 D5Mit55 51.1 het B6
D5Mit233 51.3 het B6
D5Mit394 53.0 het B6
6 D6Mit14 (63.4 cM) e DBA B6
7 D7Mit62 71.8 other B6
10 D10Mit92 77.4 DBA B6
D10Mit175 78.2 DBA B6
D10Mit42 82.3 DBA B6
11 D11Mit49 117.8 DBA B6
17 D17Mit221 88.7 het f B10
18 D18Mit161 66.2 het B6
Markers representing contiguous chromosomal segments are group together.
a Abbreviations: DBA, DBA/2J; B6, C57BL/6J; B10, C57BL/10J; other,
different from B6, DBA, and 129; het, heterozygous between B6 and DBA,
unless noted otherwise.
b BKS-db and BKS alleles are different.
c Heterozygous between B6 and 129/DBA (129 and DBA alleles are
identical).
d Heterozygous between B6 and B10.
e As physical position for this marker is not available in UniSTS, genetic
location is provided.
f Heterozygous between B6 and B10.
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This conclusion is supported by the low probability of
clustering of mutant microsatellites by chance (Table 2). In
some regions (e.g., 7 and 18), allele clustering suggests the
presence of genuine non-B6/non-DBA genomic intervals even
in the absence of SNP support. Finally, nine markers (21%)
occur isolated in chromosomal regions unsupported by SNP
studies and probably represent de novo mutation events.
About 25% of the non-B6/non-DBA markers were identical
to 129 and different from all other strains tested (B6, B10, DBA)
indicating genetic contribution from a 129 strain. Again, this
conclusion is strongly supported by the observation that 129-
derived alleles occur in clusters on Chr 4 and 15. Consistent with
previous results [12], several microsatellite markers exhibited
B10-like alleles. Four of these markers cluster together with
additional B10-like markers reported by Slingsby et al. on Chr
11, whereas the rest occur isolated on other chromosomes.
Finally, 50% of the microsatellite markers (labeled as ‘other’ in
Table 2) show alleles that are different from all strains analyzed
in this study. Importantly, these markers also occur in clusters on
several chromosomes, including Chr 5, 9, 15 and 18. These
results strongly suggest genetic contamination, as opposed to
mutation, as the source of at least some of the ‘other’ alleles in
the BKS genome. In an attempt to identify the unknown
contaminating strain, we compared allele sizes in BKS to those
in other strains catalogued in the Mouse Genome Informatics
(www.informatics.jax.org) and Center for Inherited Disease
Research (www.cidr.jhmi.edu) databases. Although some mar-
kers exhibited allele identities between BKS and other strains,
other markers within the same cluster never matched the same
strains (Supplementary Table 1). Thus, the observed allele
identities are likely random occurrences and do not reflect
genuine lineage relationships between the matching strains and
BKS. In summary, our analysis of non-B6/non-DBA alleles in
the BKS genome revealed multiple sources of genetic
contamination in this strain. In addition to the previously
reported B10-derived genetic component, we demonstrate for
the first time contributions from 129 as well as an additional,
unidentified strain in BKS.
3.3. Genetic characterization of the BKS-db and B6-db
congenic strains
The db mutation arose on the BKS genetic background and
was subsequently introduced into B6 [15]. Since the original
BKS-db strain has been lost, BKS-db mice currently available
from The Jackson Laboratory are congenic, in which the
chromosomal region harboring the db mutation is derived from
B6-db. In addition, to facilitate the identification of db/+
heterozygotes for breeding, the closely linked coat color
mutation misty (m) has also been introgressed into current
stocks of BKS-db [16]. The m mutation originally arose on the
DBA background, but was introduced to BKS-db via a B6-m
congenic (E. Leiter, personal communication). Similarly to
BKS-db, current stocks of B6-db mice also represent second
generation congenics harboring the m mutation. The complex
history of BKS-db and B6-db suggests that, apart from the dbcongenic region, these strains may carry additional chromo-
somal regions that are different from the BKS and B6
background strains, respectively. Knowledge of the chromo-
somal locations of these intervals would facilitate the genetic
analysis of phenotypic differences between BKS-db and B6-db
mice.
To identify and map donor-derived genetic material in the
BKS-db and B6-db congenic strains, we genotyped 369
microsatellite markers. As shown in Table 3, six markers in
BKS-db exhibit alleles different from BKS and 14 markers
are different between B6-db and B6. Some of these alleles
derive from neither B6 nor BKS (labeled as ‘other’ in Table
3) and occur isolated. These alleles likely represent de novo
mutations that arose since the separation of the congenic from
the parental strains. In contrast, a total of 9 markers in the
congenics exhibit DBA or B6 alleles, which are different in
the recipient strains. Most of these markers likely correspond
to contaminating genomic regions fixed during the generation
of db congenics. A clear example for such a genomic
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Chr 10 between 77.4 and 82.3 Mbp (Table 3). We also
detected heterozygosity at several chromosomal loci in B6-db,
which may reflect limited back-crossing during the develop-
ment of this congenic strain (E. Leiter, personal communi-
cation). In summary, our analysis of the BKS-db congenic
strain revealed non-BKS genetic material on three chromo-
somes (Chr 1, 17 and 19), whereas B6-db showed four non-
B6 genomic intervals (Chr 4, 6, 10 and 11) as well as several
regions of heterozygosity (Chr 4, 5, 17 and 18).
4. Discussion
In this report, we present a high-resolution microsatellite
map of the BKS genome. Consistent with other studies of this
mouse strain, a relatively high fraction (4%) of the markers we
tested exhibited non-B6/non-DBA alleles. The frequent chro-
mosomal clustering of these markers suggests that genomic
contribution from a strain(s) other than B6 and DBA is
responsible for the presence of these alleles. In contrast to recent
studies using SNPs [8,10], the use of multiallelic markers
enabled us to identify the source of non-B6/non-DBA genetic
material with high confidence. We provide evidence for the first
time that, in addition to B6 and DBA, BKS contains genetic
material from at least three other mouse strains, including 129,
B10 and an unidentified strain. We cannot exclude the
possibility that the source of non-B6/non-DBA alleles is a
single unidentified strain with 129- and B10-like alleles.
However, the observed chromosomal clustering of 129- and
B10-like markers strongly argues against this possibility, and
supports the hypothesis that contamination occurred with these
strains or a hybrid between the two. As the 129 strain originated
in the late 1920s [14] and B10 was derived in the 1930s [17],
both of these strains existed at the time when the genetic
contamination of B6 occurred [7].
One of the attractive features of the BKS strain for genetic
studies is the mosaic nature of its genome. The majority of
genetic material in BKS is derived from B6, a strain that is
resistant to diabetes induced by the db mutation. Thus,
diabetes-susceptibility genes are expected to reside in non-B6
chromosomal regions, which are present in blocks and
comprise less than 30% of the BKS genome. The fact that
genetic variation is restricted to defined blocks offers a
powerful way to reduce the size of critical intervals
underlying QTL peaks in mapping studies. The largest (20-
25%) component of non-B6 genetic material in BKS is
derived from DBA, which is a diabetes-susceptible strain.
Therefore, DBA-derived genomic blocks represent the most
likely locations of diabetes-susceptibility loci. The 129
genetic component is unlikely to contribute to diabetes-
susceptibility in BKS, as 129/J-Leprdb-3J/Leprdb-3J mice are
resistant to hyperglycemia [18]. The B10 strain is genetically
closely related to B6, therefore it is also unlikely to contribute
diabetes alleles in BKS. However, since genetically obese
B10 mice have not been evaluated for diabetes sensitivity,
this possibility cannot be fully excluded. Indeed, a B10 allele
on distal Chr 4 was reported to be associated with diabetes[19]. Finally, we uncovered a genetic component in BKS, the
origin of which is currently unknown. It is conceivable that
genetic interactions between B6 and non-B6/non-DBA alleles
contribute to diabetes sensitivity of the BKS strain. Therefore,
non-B6/non-DBA chromosomal regions should be included in
the analysis of candidate intervals.
Genetic mapping of diabetes loci in BKS requires a cross
segregating the db mutation. To initiate such a cross, two
congenic strains, B6-db and BKS-db, are used as parental
strains. As congenics often carry unwanted donor-derived
chromosomal segments, the genetic composition of the
congenics may be different from the B6 and BKS
background strains. Indeed, our analysis revealed the
presence of several donor-derived genomic regions in these
congenic strains. We identified several chromosomal regions
containing DBA-derived alleles in B6-db (Chr 4, 6, 10 and
11) and an interval in BKS-db, where a marker of unknown
origin was replaced by a B6 allele (Chr 19). Therefore, these
genomic regions are unlikely to harbor diabetes-susceptibility
loci and may be used to limit candidate intervals in QTL
mapping studies.
The B6-db and BKS-db strains have previously been used
to identify loci affecting diabetes-susceptibility. Using an F2
cross, Coleman [20] mapped a major diabetes QTL on
proximal Chr 12 to a genomic interval containing a B6-
derived segment flanked by DBA-derived regions. More
recently, Mu et al. [6] identified suggestive QTLs for plasma
glucose levels on Chr 8 and 17. Both peak QTL markers,
D8Mit195 (81.8 Mbp) and D17Mit24 (35.2 Mbp), are located
within DBA-derived genomic regions in BKS. For each of
these QTLs, knowledge of the precise boundaries of DBA
blocks results in significant reductions of the candidate QTL
intervals.
In conclusion, our studies revealed novel aspects of the
genetic composition of the diabetes-prone BKS strain, as well as
the BKS-db and B6-db congenic strains. The results presented
here will facilitate the genetic dissection of diabetes-suscepti-
bility in this mouse model and the identification of underlying
genes.
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